Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase 1 Study, Healthy Volunteers”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02125435
What this trial is testing

A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP2408
Astellas Pharma Global Development, Inc. 65
Early research (Phase 1)Study completedNCT01695876
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects

Who this might be right for
Inflammatory Disease
Amgen 58
Early research (Phase 1)Study completedNCT01937338
What this trial is testing

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

Who this might be right for
LPS Challenge, Neutrophils
AstraZeneca 60
Early research (Phase 1)Ended earlyNCT04941989
What this trial is testing

A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562

Who this might be right for
Healthy
Nxera Pharma UK Limited 33
Early research (Phase 1)Study completedNCT02956525
What this trial is testing

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

Who this might be right for
Healthy Volunteers
Apsen Farmaceutica S.A. 52
Early research (Phase 1)Study completedNCT06154447
What this trial is testing

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 165
Early research (Phase 1)Study completedNCT01906125
What this trial is testing

Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product

Who this might be right for
Healthy
Pfizer 73
Early research (Phase 1)Study completedNCT03019289
What this trial is testing

Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease

Who this might be right for
Health Volunteers, Huntington Disease
Prilenia 23
Early research (Phase 1)Study completedNCT01408394
What this trial is testing

Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Who this might be right for
Healthy
Emalex Biosciences Inc. 16
Early research (Phase 1)Study completedNCT05984251
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants

Who this might be right for
VasculitisSystemic Lupus Erythematosus (SLE)
Amgen 48
Early research (Phase 1)Study completedNCT00934453
What this trial is testing

Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers

Who this might be right for
Healthy
Massachusetts General Hospital 50
Early research (Phase 1)Study completedNCT01913379
What this trial is testing

Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole

Who this might be right for
Healthy SubjectsPharmacokineticsDrug-Drug Interaction
Astellas Pharma Europe B.V. 41
Early research (Phase 1)Study completedNCT02283827
What this trial is testing

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.

Who this might be right for
Epilepsy
Bial - Portela C S.A. 32
Early research (Phase 1)Study completedNCT06169059
What this trial is testing

To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004

Who this might be right for
Healthy Adult
Jeil Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT06091579
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants

Who this might be right for
Healthy Volunteers
Insmed Incorporated 42
Early research (Phase 1)Study completedNCT02508896
What this trial is testing

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Affiris AG 72
Early research (Phase 1)Study completedNCT07222254
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants

Who this might be right for
Healthy Participants
AstraZeneca 18
Early research (Phase 1)Study completedNCT02201056
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935

Who this might be right for
Healthy Volunteers
Takeda 48
Early research (Phase 1)Study completedNCT05511870
What this trial is testing

Etripamil in Healthy Subjects

Who this might be right for
Healthy Chinese Subjects
Corxel Pharmaceuticals 12
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation